Eagle Health Investments’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Eagle Health Investments’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-306,142	Closed	-$2.04M	–	24
2023 Q3	$2.04M	Hold	306,142	–	–	0.45%	21
2023 Q2	$2.77M	Buy	+306,142	New	+$2.7M	0.52%	26

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Eagle Health Investments's PNT Position: Q4 2023 in Review

Eagle Health Investments sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 306,142 shares — an estimated $2.04M sold.

Eagle Health Investments first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $2.77M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Eagle Health Investments reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Eagle Health Investments sold 306,142 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $2.04M.
Eagle Health Investments first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Eagle Health Investments's POINT Biopharma Global Inc. Common Stock position peaked at $2.77M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Eagle Health Investments's 13F filing for Q4 2023, filed 12 Feb 2024.